Showing results (281-290 of 427) with videos related to
Sort By:
Pageof 43
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 26, 2006
Pharmacokinetics and toxicity of weekly docetaxel in older patientsArti Hurria, Mark T Fleming, Sharyn D Baker, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
Phase II and pharmacologic study of docetaxel as initial chemotherapy for metastatic breast cancerC A Hudis, A D Seidman, J P Crown, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2025
Promoting Reasonable Career Expectations and Maximizing Professional Fulfillment for Academic Oncologists: ASCO Recommendations for Academic Medical CentersEric P Winer, Laura A Levit, Ethan Basch, et al.Breast Cancer Research and Treatment|August 21, 2001
Oral gossypol in the treatment of patients with refractory metastatic breast cancer: a phase I/II clinical trialC Van Poznak, A D Seidman, M M Reidenberg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 28, 2009
Topoisomerase II{alpha} amplification does not predict benefit from dose-intense cyclophosphamide, doxorubicin, and fluorouracil therapy in HER2-amplified early breast cancer: results of CALGB 8541/150013Lyndsay N Harris, Gloria Broadwater, Maysa Abu-Khalaf, et al.JNCI Cancer Spectrum|May 13, 2021
Physical Activity, Weight, and Outcomes in Patients Receiving Chemotherapy for Metastatic Breast Cancer (C40502/Alliance)Jennifer A Ligibel, Luke Huebner, Hope S Rugo, et al.Cancer|February 26, 2013
Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer. Translational Breast Cancer Research Consortium trial 017Jennifer F De Los Santos, Alan Cantor, Keith D Amos, et al.Journal of Clinical Pathology|July 4, 2014
Web based pathology assessment in RTOG 98-04Wendy A Woodward, Nour Sneige, Kathryn Winter, et al.Cancer|March 7, 2012
Favorable prognosis in patients with T1a/T1bN0 triple-negative breast cancers treated with multimodality therapyAlice Y Ho, Gaorav Gupta, Tari A King, et al.Breast Cancer Research : BCR|November 21, 2013
A phase 1 study evaluating the combination of an allosteric AKT inhibitor (MK-2206) and trastuzumab in patients with HER2-positive solid tumorsClifford Hudis, Charles Swanton, Yelena Y Janjigian, et al.Pageof 43